CC Grand Rounds: (1) Lentivector Gene Therapy for X-linked Severe Combined Immune Deficiency (XSCID) in Older Children, Young Adults with Impaired Immunity and Recurrent Infections Despite Prior Haplo-transplant and 2) A New Approach to Cancer Immunotherapy Targeting Unique Cancer Mutations

Date: Wednesday, 09 30, 2015; Speaker: Harry L. Malech, MD, Chief, Laboratory of Host Defenses and , Chief, Genetic Immunotherapy Section, NIAID; Steven A. Rosenberg, MD, PhD, Chief, Surgery Branch, NCI; Building: Building 10 (Clinical Center); Lipsett Amphitheater; CME Credit; Videocast Event
Source: NIH Calendar of Events - Category: American Health Source Type: events